AFP and hepatocellular carcinoma: Although the serum alpha-fetoprotein (AFP) test is routinely used for risk stratification of hepatocellular carcinoma [4], its sensitivity and specificity are significantly limited, making it difficult to provide accurate diagnosis and support treatment using this test.